Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Science News / India's second COVID-19 vaccine cleared for human trials: Details here
  • Science

    India's second COVID-19 vaccine cleared for human trials: Details here

    Shubham Sharma
    Written by
    Shubham Sharma
    Twitter
    Last updated on Jul 03, 2020, 12:44 pm
    India's second COVID-19 vaccine cleared for human trials: Details here
  • India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.

    Just a few days ago, Bharat Biotech's 'COVAXIN' became the first indigenously developed COVID-19 shot to be approved for clinical human trials, and now, Ahmedabad-based Zydus Cadila Healthcare is set to join the bandwagon with its own candidate.

    Separately, ICMR plans to launch COVAXIN by August 15.

  • In this article
    Approved for Phase 1 and 2 of human trials Satisfactory results in pre-clinical animal trials What will happen in Phase 1, 2 trials? After that, Phase 3 trial will be carried out India now has 2 approved vaccines in clinical trials 18 candidates from other countries moving through human trials
  • Approval

    Approved for Phase 1 and 2 of human trials

    Approved for Phase 1 and 2 of human trials
  • According to reports, one of Zydus Cadila's two experimental vaccines has been cleared for Phase 1, 2 of clinical human trials.

    The data related to the shot was examined by the Drugs Controller General of India, following which the nod to start the tests with human volunteers was given.

    The approval process was expedited on the suggestion of DCGI's expert committee on COVID-19.

  • Animal trials

    Satisfactory results in pre-clinical animal trials

    Satisfactory results in pre-clinical animal trials
  • A senior government official told ANI that the vaccine candidate was tested on animals like mice, rabbits, guinea pigs, and was able to generate the required antibodies to fight off the virus.

    "Their animal trial data was inspected thoroughly and was found satisfactory. And now, DCGI has granted permission to Zydus Cadila to conduct Phase 1 & 2 clinical trial," the official added.

  • Details

    What will happen in Phase 1, 2 trials?

  • In the trials, the candidate vaccine will be tested on hundreds of human volunteers to determine how safely and effectively it can generate an immune response.

    It is not clear when the tests will begin but an official familiar with the developments told PTI that the enrollment of subjects will start soon and the study will take around 3 months to be completed.

  • Phase 3

    After that, Phase 3 trial will be carried out

    After that, Phase 3 trial will be carried out
  • Once the initial phases are over, the vaccine will move into the third and final stage of human trials, where it will be tested on thousands of people.

    After that, using all the data, the effectiveness and safety of the vaccine will be confirmed and reviewed, lining the shot up for emergency use approvals.

    The entire process could take months from now.

  • Vaccines

    India now has 2 approved vaccines in clinical trials

  • With this, India has now cleared two potential vaccines for the clinical trial phase.

    The first one, COVAXIN by ICMR and Bharat Biotech, was approved just a few days ago and is now being fast-tracked through the tests at 12 institutes across the country.

    ICMR has also said it is targeting to make COVAXIN available for emergency public use by August 15.

  • Other candidates

    18 candidates from other countries moving through human trials

    18 candidates from other countries moving through human trials
  • From other nations, we have as many as 18 experimental vaccines that are moving through clinical trials.

    Of these, most (8, to be specific) are from China, but the front-runners are candidates from UK's AstraZeneca and America's Moderna Therapeutics.

    AstraZeneca has also partnered with the Serum Institute of India to manufacture a billion doses for India and low-to-middle income nations.

  • PTI
  • ANI
  • Drugs Controller General of India
  • Zydus Cadila
  • Coronavirus
  •  
Latest News
  • Ahead of launch, Meizu 18 series' camera system teased
    Ahead of launch, Meizu 18 series' camera system teased
    Science
  • Employee sues Amazon for racial, gender discrimination in corporate hiring
    Employee sues Amazon for racial, gender discrimination in corporate hiring
    Business
  • Realme C21, with 5,000mAh battery, to debut on March 5
    Realme C21, with 5,000mAh battery, to debut on March 5
    Science
  • Alec Baldwin, wife Hilaria welcome their sixth child
    Alec Baldwin, wife Hilaria welcome their sixth child
    Entertainment
  • NewsBytes Briefing: Amazon accused of discriminating against blacks, and more
    NewsBytes Briefing: Amazon accused of discriminating against blacks, and more
    Science
Related Timelines
  • SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    India
  • India's neighbors train experts for clinical trials of COVID-19 vaccine
    India's neighbors train experts for clinical trials of COVID-19 vaccine
    India
  • Russia's Sputnik V to start human trials in India soon
    Russia's Sputnik V to start human trials in India soon
    Science
  • COVAXIN animal trials confirmed to be successful: Details here
    COVAXIN animal trials confirmed to be successful: Details here
    Science
Trending Topics
Samsung OnePlus Mobiles Android TV Smart TV Latest Gadget Launch MediaTek Dimensity 1000+ COVAXIN Latest Tech News Upcoming Mobile Phones
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Science news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Twitter Indian Premier League Samsung Virat Kohli
Rohit Sharma Cricket News YouTube Hollywood News WhatsApp Bollywood News Real Madrid ISRO Yoga Honda
Batman Football News BMW Novak Djokovic Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Prince Philip
Toyota Fashion Tips Mercedes La Liga Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Bobby Deol
Marvel Comics Avengers Neha Kakkar Premier League
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021